The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.

Astrana Health completes a $708 million acquisition that it announced in 2024.

The company’s platform aims to help commercial and medical affairs teams automate manual and rote tasks.

The spin-off company is expected to rake in almost $2 billion in revenue this year.

MAI-DxO AI reportedly diagnosed complex medical cases with over four times higher accuracy than generalist physicians and saved costs.

The acquisition, part of a strategic partnership to accelerate Arcadia’s growth and innovation, marks an exit for former investor Peloton Equity.

Also, new mobile applications promoting mental wellbeing have been launched.

A Taiwanese startup has received the US FDA’s 510(k) clearance for its neurosurgical robot.

Suki, an AI-backed voice tool for healthcare, announced its expanded integration with MEDITECH, an EHR company, enabling Suki to generate and forward clinically-generated notes directly into…

The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.